| Scrip code | 000000 |
|---|---|
| NSE Symbol | QMSMEDI |
| MSEI Symbol | NOTLISTED |
| ISIN | INE0FMW01018 |
| Name of Company | QMS MEDICAL ALLIED SERVICES LIMITED |
| Type of company | SME |
| Class of security | Equity |
| Date of start of financial year | 01-04-2025 |
| Date of end of financial year | 31-03-2026 |
| Date of board meeting when results were approved | 14-02-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 09-02-2026 |
| Description of presentation currency | INR |
| Level of rounding used in financial results | Lakhs |
| Reporting Type | Quarterly |
| Reporting Quarter | Third quarter |
| Nature of report standalone or consolidated | Standalone |
| Whether results are audited or unaudited for the quarter ended | Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | Unaudited |
| Segment Reporting | Single segment |
| Description of single segment | Healthcare Equipments |
| Start date and time of board meeting | 14-02-2026 13:00:00 |
| End date and time of board meeting | 14-02-2026 15:15:00 |
| Whether cash flow statement is applicable on company | |
| Type of cash flow statement | |
| Declaration of unmodified opinion or statement on impact of audit qualification | Not applicable |
| Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? | Yes |
| No. of times funds raised during the quarter | 1 |
| Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? | No |
| There are no Debt Securities in the Company and no Defaults on Loans and Debt Securities by the Company. | |
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-10-2025 | 01-04-2025 |
| B | Date of end of reporting period | 31-12-2025 | 31-12-2025 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Standalone | Standalone |
| 1 | Revenue From Operations | ||
| Revenue from operations | 2,953.51 | 11,310.53 | |
| Other income | 12.92 | 28.37 | |
| Total Income | 2,966.43 | 11,338.90 | |
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 0.00 | 0.00 |
| (b) | Purchases of stock-in-trade | 2,106.97 | 7,483.60 |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | (549.96) | (884.25) |
| (d) | Employee benefit expense | 275.48 | 802.47 |
| (e) | Finance costs | 206.01 | 555.17 |
| (f) | Depreciation and amortisation expense | 91.53 | 250.15 |
| (g) | Other Expenses | ||
| 1 | other expenses | 744.41 | 2,292.29 |
| Total other expenses | 744.41 | 2,292.29 | |
| Total expenses | 2,874.44 | 10,499.43 | |
| 3 | Profit before exceptional and extraordinary items and tax | 91.99 | 839.47 |
| 4 | Exceptional items | 0.00 | 0.00 |
| 5 | Profit before extraordinary items and tax | 91.99 | 839.47 |
| 6 | Extraordinary items | 0.00 | 0.00 |
| 7 | Profit before tax | 91.99 | 839.47 |
| 8 | Tax Expense | ||
| Current tax | 29.26 | 213.75 | |
| Deferred tax | 5.03 | 34.10 | |
| Total tax expenses | 34.29 | 247.85 | |
| 9 | Net Profit Loss for the period from continuing operations | 57.70 | 591.62 |
| 10 | Profit (loss) from discontinuing operations before tax | 0.00 | 0.00 |
| 11 | Tax expense of discontinuing operations | 0.00 | 0.00 |
| 12 | Net profit (loss) from discontinuing operation after tax | 0.00 | 0.00 |
| 13 | Profit (loss) for period before minority interest | 57.70 | 591.62 |
| 14 | Share of profit (loss) of associates | ||
| 15 | Profit (loss) of minority interest | ||
| 16 | Net profit (Loss) for the period | 57.70 | 591.62 |
| 17 | Details of equity share capital | ||
| Paid-up equity share capital | 1,933.74 | 1,933.74 | |
| Face value of equity share capital | 10 | 10 | |
| 18 | Reserves excluding revaluation reserve | ||
| 19 | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | 0.3 | 1.29 | |
| Diluted earnings (loss) per share from continuing and discontinued operations | 0.3 | 1.29 | |
| 20 | Debt equity ratio | 0.2900 | 0.2900 |
| 21 | Debt service coverage ratio | 0.7400 | 1.1400 |
| 22 | Interest service coverage ratio | 1.9800 | 3.0700 |
| 23 | Disclosure of notes on financial results | ||
| 20 | Debt equity ratio | |
|---|---|---|
| 21 | Debt service coverage ratio | |
| 22 | Interest service coverage ratio |
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|---|
| Date of start of reporting period | 01-10-2025 | 01-04-2025 | |||||
| Date of end of reporting period | 31-12-2025 | 31-12-2025 | |||||
| Whether results are audited or unaudited | Unaudited | Unaudited | |||||
| Nature of report standalone or consolidated | Standalone | Standalone | |||||
| 1 | Segment Revenue (Income) | ||||||
| (net sale/income from each segment should be disclosed) | |||||||
| Total Segment Revenue | |||||||
| Less: Inter segment revenue | |||||||
| Revenue from operations | |||||||
| 2 | Segment Result | ||||||
| Profit (+) / Loss (-) before tax and interest from each segment | |||||||
| Total Profit before tax | |||||||
| i. Finance cost | |||||||
| ii. Other Unallocable Expenditure net off Unallocable income | |||||||
| Profit before tax | |||||||
| 3 | (Segment Asset - Segment Liabilities) | ||||||
| Segment Asset | |||||||
| Total Segment Asset | |||||||
| Un-allocable Assets | |||||||
| Net Segment Asset | |||||||
| 4 | Segment Liabilities | ||||||
| Segment Liabilities | |||||||
| Total Segment Liabilities | |||||||
| Un-allocable Liabilities | |||||||
| Net Segment Liabilities | |||||||
| Disclosure of notes on segments | |||||||
| Mode of Fund Raising | Rights Issues |
|---|---|
| Description of mode of fund raising (Applicable in case of others is selected) | |
| Date of Raising Funds | 23-09-2025 |
| Amount Raised | 1,204.83 |
| Report filed for Quarter ended | 31-12-2025 |
| Monitoring Agency | Applicable |
| Monitoring Agency Name, if applicable | CARE Ratings Limited |
| Is there a Deviation / Variation in use of funds raised | No |
| If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders | |
| If Yes, Date of shareholder Approval | |
| Explanation for the Deviation / Variation | Not Applicable |
| Comments of the Audit Committee after review | NIL |
| Comments of the auditors, if any | NIL |
| Sr. | Original Object | Modified Object, if any | Original Allocation | Modified allocation, if any | Funds Utilised | Amount of Deviation/Variation for the quarter according to applicable object | Remarks if any |
| 1 | Acquisition of Further 25% in Subsidiary, resulting in 76 Holding | Not Applicable | 1,000.00 | 0.00 | 1,000.00 | 0.00 | |
| 2 | Offer Related Expenses | Not Applicable | 170.00 | 0.00 | 170.00 | 0.00 | |
| 3 | Funding expenditure for General Corporate Purposes | Not Applicable | 34.88 | 34.83 | 34.24 | 0.00 | The total issue size was Rs.1,204.88 lakhs, while the actual funds received amounted to Rs.1,204.83 lakhs. As this was an SME Rights Issue, wherein allotment must be made in the prescribed lot size of 83 equity shares, the final allotment resulted in a shortfall of 57 equity shares, leading to the minor difference between the issue size and the funds received. Accordingly, the same has been adjusted in Funding expenditure for General Corporate Purposes. |
| Name of signatory | Mahesh Makhija |
| Designation of person | Managing Director |
| Place | Mumbai |
| Date | 14-11-2025 |